Low-risk papillary thyroid carcinoma
clinical outcomes of active surveillance management
DOI:
https://doi.org/10.11606/issn.1679-9836.v98i6p403-407Keywords:
Watchful waiting, Thyroid cancer, papillary, Thyroid neoplasms, Active surveillanceAbstract
Introduction: A epidemic increase in the incidence of papillary thyroid carcinoma (PTC) has been happening within the last 25 years. The majority of those tumors are low-risk, and some studies reported low progression rates of low-risk PTC. It suggests that immediate surgery may not be the best option, specially when considering the intrinsic risk to a thyroidectomy and inconvenience of lifelong hormone replacement. In this systematic review we compare the outcomes of active surveillance for the primary management of low-risk PTC. Methods: The review was conducted based on three studies selected from specific databases. These studies followed up low-risk patients nonoperatively and surgery was performed if needed. Results: All studies reported low percentages of tumor growth and metastatic disease during active surveillance. Furthermore, no significant differences between immediate surgery and late rescue surgery were reported, and active surveillance appears to be cheaper than the tradicional conduct. Conclusions: Active surveillance seems to be a good alternative for low-risk PTC management, yet, more long-term and bigger research is still needed, specially outside of a japanese population.
Downloads
References
2. Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic” - screening and overdiagnosis. N Engl J Med. 2014;371:1765-7. doi: 10.1056/NEJMp1409841.
3. Sobin LH, Gospodarowicz MK, Wittekind C. UICC International Union Against Cancer, TNM Classification of Malignant Tumours. 7th ed. United States; 2011. p.22-45.
4. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1-133. doi: 10.1089/thy.2015.0020.
5. Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27-34. doi: 10.1089/thy.2013.0367
6. Tuttle RM, Fagin JA, Minkowitz G, Wong RJ, Roman B, Patel S, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143(10):1015-20. doi: 10.1001/jamaoto.2017.1442.
7. Sakai T, Sugitani I, Ebina A, Fukuoka O, Toda K, Mitani H, et al. Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid. 2019;29(1):59-63. doi: 0.1089/thy.2018.0462.
8. Oda H, Miyauchi A, Ito Y, Sasai H, Masuoka H, Yabuta T, et al. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid. Endocr J. 2017;64(1):59-64. doi: 10.1507/endocrj.EJ16-0381.
